Patients with atrial fibrillation face higher bleeding risks when treated with 2 common medications
Medical Xpress
February 27, 2026
Patients with atrial fibrillation who are prescribed diltiazem to control heart rate alongside anticoagulants (blood thinners) such as apixaban or rivaroxaban face a higher risk of serious bleeding compared with those taking metoprolol, according to a new study from Vanderbilt Health researchers and colleagues at the Perelman School of Medicine.
Verticals
healthmedical
Originally published on Medical Xpress on 2/27/2026